I think this is a case of Merck, Novartis or Glaxo paying up to grab the full rights to their IP of interest. There are actually three shots at a massive cash payment. Does not have to be a takeover to massively reward SH in a hurry. SP would rise dramatically even if such an offer arose and was discussed I suspect, even if not taken up.
However I suspect with a longer term horizon we are significantly better off to keep supporting IMM with capital when they need it, and share the fat eventual profits and distributions then. The SP should keep growing with good news as the drugs get closer to market.
Ann: Change in substantial holding, page-9
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.0¢ | 31.0¢ | $306.8K | 972.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 178587 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 44597 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |